Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).
Clinical trial NCT04452474 · WITHDRAWN
Trial details
- NCT number
- NCT04452474
- Sponsor
- R-Pharm
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2020-11-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.